Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01496209

REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Cedars-Sinai Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A double blinded and placebo-controlled, dose escalation, single-center safety and preliminary efficacy study of cardiospheres delivered via NOGA MYOSTAR injection catheter in subjects with chronic ischemic cardiomyopathy. The objective is to achieve and document myocardial regeneration in patients with chronic scar.

Conditions

Interventions

TypeNameDescription
BIOLOGICALEndomyocardial injections of allogeneic Human CSpsNOGA electromechanical mapping and endomyocardial injections at 15 peri-infarct sites, via NOGA MYOSTAR catheter, of Allogeneic Human CSps.
BIOLOGICALEndomyocardial injections of vehicle only.NOGA electromechanical mapping and endomyocardial injections at 15 peri-infarct sites, via NOGA MYOSTAR catheter, of placebo.

Timeline

Start date
2015-07-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2011-12-21
Last updated
2014-02-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01496209. Inclusion in this directory is not an endorsement.